抗毒素市場：抗毒素タイプ別、製品タイプ別、エンドユーザー別、地域別

抗毒素の世界市場は、2025年には13億8,200万米ドルと推定され、2032年には24億9,570万米ドルに達すると予測され、2025年から2032年までのCAGRは8.8%で成長すると予測されています。

図.2025年抗毒素市場の地域別シェア（%）

世界の抗毒素市場の成長は、世界の熱帯・亜熱帯地域におけるヘビによる咬傷とサソリによる刺傷の発生率の上昇に牽引されています。毎年500万人以上がヘビに咬まれ、そのうち約270万件が中毒を起こし、約10万人が死亡しています。有効な駆除薬が入手可能になったことで、多くの国でヘビに咬まれた被害者の生存率や回復率が向上したため、駆除薬の需要が高まっています。大手メーカーは、最新の免疫学的・生化学的手法を用いた生産技術の改革を通じて、新規の抗ベノムの開発に取り組んでいます。適時の治療と抗ベノムの入手可能性に関する認識醸成に向けた投資の増加も、市場の成長を促進する可能性があります。

市場力学：

世界の抗毒素市場の成長は、主に世界のヘビ咬傷とサソリ刺傷の発生率の増加が牽引しています。世界保健機関（WHO）によると、毎年約540万人がヘビにかまれ、約270万人が刺され、約13万7000人が死亡しています。市場関係者や政府は、農村部の住民を教育し、ヘルスケア施設へのアクセスを改善し、遠隔地における抗毒素の利用可能性を確保するために投資を増やしています。しかし、抗ベノムはコストが高く、保存期間が短いため保管や輸送に制約や管理が必要であることから、その普及には限界があります。認識不足、伝統的な信仰、地理的な障壁が、発展途上国の被害者がタイムリーに治療を受けられるよう制限しています。革新的で、より効果的かつ手頃な価格の抗ベノムを研究・生産している市場関係者は、市場の成長機会を提供することができます。

本調査の主な特徴

• 本レポートでは、世界の抗毒素市場を詳細に分析し、2022年を基準年とした予測期間（2025-2032年）の市場規模および複合年間成長率（CAGR%）を掲載しています。
• また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案マトリクスについて解説しています。
• また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
• 企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界の抗毒素市場の主要企業をプロファイルしています。
• このレポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品の発売、タイプのアップグレード、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
• 世界の抗毒素市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界のさまざまな利害関係者に対応しています。
• 利害関係者は、世界の抗毒素市場の分析に使用される様々な戦略マトリックスを通じて意思決定を容易にすることができます。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー
• Coherent Opportunity Map（COM）

第3章 市場力学、規制、動向分析

• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• 影響分析
• 市場動向
• 主な発展
• 規制シナリオ
• 買収と提携のシナリオ
• 資金調達と投資
• PEST分析
• ポーターの分析

第4章 世界の抗毒素市場- コロナウイルス（COVID-19）パンデミックの影響

• 全体的な影響
• 政府の取り組み
• COVID-19による市場への影響

第5章 世界の抗毒素市場、抗毒素タイプ別、2020年-2032年

• 多価
• 一価

第6章 世界の抗毒素市場、製品タイプ別、2020年-2032年

• ヘビの抗毒素
• サソリの抗毒素
• クモの抗毒素
• その他

第7章 世界の抗毒素市場、エンドユーザー別、2020年-2032年

• 病院・クリニック
• 外来手術センター
• 研究機関
• その他

第8章 世界の抗毒素市場、地域別、2020年-2032年

• 北米
• ラテンアメリカ
• 欧州
• アジア太平洋
• 中東
• アフリカ

第9章 競合情勢

• 企業プロファイル
  • Pfizer, Inc.
  • Merck &Co., Inc.
  • Sanofi Pasteur
  • 4CSL Limited
  • Haffkine Bio-Pharmaceutical Corporation Ltd.
  • Instituto Bioclon SA de CV
  • Rare Disease Therapeutics, Inc.
  • Vins Bioproducts Limited
  • Bharat Serums and Vaccines Limited
  • Serum Institute of India Pvt. Ltd.
  • Incepta Pharmaceuticals Ltd.
  • MicroPharm Limited
  • Laboratorios Silanes SA
  • BTG plc
  • Vacsera
  • Indian Immunologicals Limited
  • AfrIPI（African Institute of Biomedical Science and Technology）

第10章 アナリストの推奨事項

• 機会
• アナリストの見解
• Coherent Opportunity Map

第11章 参考文献と調査手法

• 参考文献
• 調査手法

Global Anti Venom Market is estimated to be valued at USD 1,382.0 Mn in 2025 and is expected to reach USD 2,495.7 Mn by 2032, growing at a compound annual growth rate (CAGR) of 8.8% from 2025 to 2032.

Figure. Anti Venom Market Share (%), By Region 2025

Global anti venom market growth is driven by rising incidence of snake bites and scorpion stings across tropical and sub-tropical regions of the world. Each year over 5 million people are bitten by snakes, out of which, around 2.7 million cases result in envenoming and around 100,000 deaths. There has been rising demand for anti-venom as the availability of effective anti-venoms has improved survival and recovery rates for victims of snake bites in many countries. Leading manufacturers are engaging in development of novel anti-venoms through reforms in production techniques using modern immunological and biochemical methods. Rising investments towards building awareness about timely treatment and availability of anti-venoms can also drive the market growth.

Market Dynamics:

Global anti venom market growth is primarily driven by increasing incidence of snake bites and scorpion stings globally. According to the World Health Organization, around 5.4 million people suffer from snake bites each year and about 2.7 million are envenomed with around 137,000 deaths. Rising investments by market players and governments towards educating rural populations, improving access to healthcare facilities and ensuring availability of anti-venoms across remote areas can offer lucrative opportunities. However, high costs of anti-venoms, short shelf-life requiring constrained and controlled storage and transportation can limit its widespread adoption. Lack of awareness, traditional beliefs and geographical barriers restrict timely treatment seeking for victims in developing nations. Market players involved in research and production of innovative, more effective and affordable anti-venoms can offer market growth opportunities.

Key features of the study:

• This report provides in-depth analysis of the global anti venom market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global anti venom market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Bharat Serums & Vaccines, Haffkine Bio-Pharmaceutical Corporation, Vins Bioproducts, Bharat Biotech, and Serum Institute of India
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global anti venom market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global anti venom market

Detailed Segmentation-

• By Anti-venom Type
  • Polyvalent
  • Monovalent
• By Product Type
  • Snake Antivenom
  • Scorpion Anti-venom
  • Spider Anti-venom
  • Others
• By End User
  • Hospitals & clinics
  • Ambulatory Surgical Centers
  • Research Institutes
  • Others
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Pfizer, Inc.
  • Merck & Co., Inc.
  • Sanofi Pasteur
  • 4CSL Limited
  • Haffkine Bio-Pharmaceutical Corporation Ltd.
  • Instituto Bioclon S.A. de C.V.
  • Rare Disease Therapeutics, Inc.
  • Vins Bioproducts Limited
  • Bharat Serums and Vaccines Limited
  • Serum Institute of India Pvt. Ltd.
  • Incepta Pharmaceuticals Ltd.
  • MicroPharm Limited
  • Laboratorios Silanes S.A.
  • BTG plc
  • Vacsera
  • Indian Immunologicals Limited
  • AfrIPI (African Institute of Biomedical Science and Technology)

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Anti-venom Type
  • Market Snapshot, By Product Type
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Anti Venom Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Anti Venom Market, By Anti-venom Type, 2020 - 2032, (USD Mn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Polyvalent
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Monovalent
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Anti Venom Market, By Product Type, 2020 - 2032, (USD Mn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Snake Antivenom
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Scorpion Anti-venom
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Spider Anti-venom
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Anti Venom Market, By End User, 2020 - 2032, (USD Mn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospitals & Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Ambulatory Surgical Centers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Research Institutes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Anti Venom Market, By Region, 2020 - 2032, (USD Mn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Anti-venom Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Anti-venom Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Anti-venom Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Anti-venom Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Anti-venom Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Anti-venom Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Mn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • Pfizer, Inc.
    • Company Highlights
    • Anti-venom Type Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Merck & Co., Inc.
    • Company Highlights
    • Anti-venom Type Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sanofi Pasteur
    • Company Highlights
    • Anti-venom Type Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • 4CSL Limited
    • Company Highlights
    • Anti-venom Type Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Haffkine Bio-Pharmaceutical Corporation Ltd.
    • Company Highlights
    • Anti-venom Type Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Instituto Bioclon S.A. de C.V.
    • Company Highlights
    • Anti-venom Type Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Rare Disease Therapeutics, Inc.
    • Company Highlights
    • Anti-venom Type Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Vins Bioproducts Limited
    • Company Highlights
    • Anti-venom Type Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bharat Serums and Vaccines Limited
    • Company Highlights
    • Anti-venom Type Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Serum Institute of India Pvt. Ltd.
  • Incepta Pharmaceuticals Ltd.
  • MicroPharm Limited
  • Laboratorios Silanes S.A.
  • BTG plc
  • Vacsera
  • Indian Immunologicals Limited
  • AfrIPI (African Institute of Biomedical Science and Technology)

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact